Showing results (271-280 of 366) with videos related to
Sort By:
Pageof 37
Health Technology Assessment (Winchester, England)|September 13, 2005
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritisD Symmons, K Tricker, C Roberts, et al.Analytical Chemistry|August 1, 1997
Calibration of micropipets using the bioluminescent protein aequorinA L Grosvenor, C L Crofcheck, K W Anderson, et al.Annals of the Rheumatic Diseases|January 1, 1993
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanismsA R Moore, H Iwamura, J P Larbre, et al.Annals of the Rheumatic Diseases|August 1, 1984
Laminin and vascular proliferation in rheumatoid arthritisD L Scott, M Salmon, C J Morris, et al.The Journal of Surgical Research|January 25, 2000
Are gastric, jejunal, or both forms of enteral feeding gastroprotective during stress?K S Ephgrave, D L Scott, A Ong, et al.Rheumatology International|January 1, 1985
Differences between plasma and synovial fluid fibronectinD L Scott, S D Carter, J S Coppock, et al.Rheumatology (Oxford, England)|December 10, 1999
The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritisD L Mattey, A B Hassell, M J Plant, et al.British Journal of Rheumatology|May 1, 1985
Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugsK A Grindulis, D L Scott, M W Robinson, et al.Rheumatology (Oxford, England)|February 22, 2003
Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositisY-L Chung, W S Wassif, J D Bell, et al.Neurology|March 29, 2007
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)K A Vincent, A J Carr, J Walburn, et al.Pageof 37